SCHEMBL1489747

SCHEMBL1489747

C=CCOc1c(C)cc(-c2nnc(N(CC3CC3)C(=O)c3ccccc3Cl)s2)cc1C

nearest known ligand 0.49

Predicted protein targets (top 8)

geneUniProtsupporting neighboursconfidence
S1PR1 P21453 16/20 0.49
S1PR3 Q99500 6/20 0.43
ALDH1A1 P00352 3/20 0.40
KDM4E B2RXH2 1/20 0.37
TP53 P04637 1/20 0.37
HSD17B10 Q99714 1/20 0.37
S1PR4 O95977 1/20 0.36
S1PR5 Q9H228 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1489469 0.93 S1PR1 (0.50) S1PR1S1PR3ALDH1A1KDM4ETP53
SCHEMBL1489133 0.91 S1PR1 (0.47) S1PR1S1PR3ALDH1A1KDM4ETP53
SCHEMBL1489066 0.90 S1PR1 (0.49) S1PR1S1PR3ALDH1A1KDM4ETP53
SCHEMBL12830866 0.90 S1PR1 (0.42) S1PR1S1PR3ALDH1A1KDM4ETP53
SCHEMBL1489212 0.89 S1PR1 (0.51) S1PR1S1PR3ALDH1A1KDM4ETP53
SCHEMBL1489009 0.89 S1PR1 (0.49) S1PR1S1PR3ALDH1A1S1PR4S1PR5
SCHEMBL1489113 0.87 S1PR1 (0.55) S1PR1S1PR3ALDH1A1KDM4EHSD17B10
SCHEMBL1489008 0.87 S1PR1 (0.48) S1PR1S1PR3ALDH1A1
SCHEMBL12779879 0.86 S1PR1 (0.62) S1PR1S1PR3ALDH1A1KDM4EHSD17B10
SCHEMBL1489060 0.84 S1PR1 (0.47) S1PR1S1PR3ALDH1A1KDM4ETP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2305660-A1 New thiadiazole derivatives Almirall, S.A. (ES) 2011-04-06 EP disclosed
EP-2305660-A1 New thiadiazole derivatives Almirall, S.A. (ES) 2011-04-06 EP disclosed
WO-2011035900-A1 NEW THIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-03-31 WO disclosed
WO-2011035900-A1 NEW THIADIAZOLE DERIVATIVES ALMIRALL, S.A. (ES) 2011-03-31 WO disclosed